Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
startups
4
×
vc
4
×
biotech
boston blog main
boston top stories
financing
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
accenture
aducanumab
advocate aurora health
alnylam
alzheimer's disease
amblyotech
arena pharmaceuticals
artie suckow
asklepios biopharmaceutical
azacitidine
beta-thalassemia
bioeurope
biogen
biomarin pharmaceutical
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
children’s hospital of wisconsin
What
medicines
new
developing
drugs
activity
advance
aims
approach
approvals
based
bio
biogen
biologics
biotech
called
catch
clamped
communities
considered
covid
deal
debuts
delays
deliver
diseases
dtx
economic
epic
epigenetic
epigenetics
fast
fda
field
flagship’s
happenings
hitting
including
innovation
investors
ipo
Language
unset
4
×
Current search:
vc
×
unset
×
startups
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
WI Watchlist: Epic, Shine, Venture Investors, Stratatech & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
